Battley Leaves Executive Role at Aurora Cannabis

Aurora Cannabis (TSX: ACB) (NYSE: ACB) has seen its chief corporate officer Cam Battley step down from his role effective December 20, 2019. The rumour, initially spread across multiple social media channels, was quickly confirmed via a press release following the leak of an email that was sent out to employees late yesterday.

The press release follows a quick tweet-storm that began with twitter user @bettingbruiser release a screenshot of the email sent to Aurora employees last night. The email detailed that Battley had stepped down from the role yesterday.

As per the just-released press release, Battley stepped down yesterday for undisclosed reasons. A replacement has not been named in the CCO role following Battley’s departure. Instead, those of whom previously reported to Battley are now believed to be reporting directly to that of chief executive officer Terry Booth. Battley, despite the departure, has been named to the board of directors of Medreleaf Australia.

The news follows a week that truly can’t seem to end for Aurora investors. As The Deep Dive highlighted yesterday, a director this week quietly filed with Sedi last night that he had sold 57% of his total equity ownership in the company. This was shortly following a research report which placed a zero dollar price target on the firm.

Aurora Cannabis last traded at $2.95 on the TSX.

Information for this briefing was found via Sedar and Aurora Cannabis. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.